STREAMLINE HEALTH SOLUTIONS INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022	FY2021 12 months to Jan 31, 2021
Cash flows from operating activities:
Net loss
LESS: Income from discontinued operations, net of tax
Loss from continuing operations, net of tax
Depreciation
Total amortization expense on internally-developed software
Amortization of capitalized software development costs
Amortization of intangible assets
Amortization of other deferred costs
Amortization of Deferred Financing Costs
Valuation adjustments
Depreciation and amortization
Acquisition earnout valuation adjustments
Loss on early extinguishment of debt
Provision for income taxes
Provision (benefit) for income taxes
Loss on exit of operating lease
Provision for deferred income taxes

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Accrued interest expense - notes payable
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)
Benefit for deferred income taxes
Share-based compensation expense
Impairment of goodwill
Impairment of long-lived assets
Forgiveness of PPP loan
Provision for credit losses

Changes in assets and liabilities:
Accounts and contract receivables
Other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenues
Net cash used in operating activities – continuing operations
Net cash provided by operating activities – discontinued operations
Deferred revenues
Net cash used in operating activities
Cash flows from investing activities:
Investment in Avelead, net of cash acquired
Purchases of property and equipment
Proceeds from sale of ECM Assets
Capitalization of software development costs
Net cash provided by (used in) investing activities - continuing operations
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of common stock
Payment of acquisition earnout liabilities
Payments for costs directly attributable to the issuance of common stock
Repayment of bank term loan
Proceeds from term loan payable
Repayment of line of credit
Proceeds from line of credit
Proceeds from notes payable
Repurchase of common shares to satisfy employee tax withholding
Payment of deferred financing costs
Payment on royalty liability
Other
Net cash (used in) provided by financing activities - continuing operations
Net cash provided by financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Supplemental cash flow disclosures:
Interest paid, net of amounts capitalized
Income taxes paid

Comments